《大行報告》富瑞升康師傅(00322.HK)評級至「買入」 上調目標價至15元
富瑞發表報告指,考慮到公司指引,將康師傅(00322.HK)2022至2024年度淨利潤預測分別提高6%、4%及6%,而銷售額下調幅度不到1%。該行認爲,公司上半年業績與相對更積極的前景和宣佈的特別中期股息相一致,將其投資評級由「持有」升至「買入」,目標由13.88元升至15元。
富瑞指,公司上半年銷售額與預期一致,而淨利潤比該行預期低6%,主要是由於其他收入減少。公司今年純利指引介乎25億至30億人民幣之間,該行認爲是合理的水平。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.